Retatrutide Revolution: The Triple-Threat Agonist Redefining Weight Loss & Beyond

Welcome back to The Human 5.0 Project – where we upgrade the human operating system.

In today’s episode we go full-send on Retatrutide , Eli Lilly’s triple-agonist that just obliterated every weight-loss record in 2025: up to 24.2% body weight loss in 48 weeks (that’s 50–60+ lbs for most people) with simultaneous improvements in A1c, liver fat, blood pressure, and triglycerides. People are already calling it the “Ozempic killer” and the first true “programmable metabolism” molecule.

Here’s exactly what we cover in this 9-minute deep dive:

• What Retatrutide actually is (GLP-1 + GIP + Glucagon triple action explained simply)
• Why the glucagon receptor makes it burn fat differently than Semaglutide or Tirzepatide
• Real phase-2/phase-3 dosing schedules (0.5 mg → 12 mg titration)
• The smartest peptide & supplement stacks in 2025 (Tesamorelin, CJC/Ipamorelin, BPC-157, NMN, berberine, etc.)
• How the biohacking underground is microdosing it (0.25–1 mg pulses) for slow, sustainable, rebound-proof results
• Current safety profile & what to watch for

If you’re into fat-loss, metabolic longevity, or just want to see what the next generation of incretin drugs can actually do, this is the episode.

 

Drop a comment: Are you Team Tirzepatide or jumping straight to Retatrutide when it drops? 👇

 

🔥 Subscribe for no-BS biohacking & longevity drops

Follow on IG @Ultimatebiohacker10X

For more longevity insights and protocols, check out biohackerdepot.com – your go-to resource for cutting-edge health optimization strategies.

And if you're sourcing research peptides , peptidesphere.com has a curated selection of peptides and bioregulators with detailed info on quality and applications.

 

#Retatrutide #TripleAgonist #WeightLoss2025 #OzempicKiller #GLP1 #Biohacking #Longevity #FatLoss #MicrodosingPeptides #MetabolicHealth #EliLilly #Human50 #PeptideStack #Type2Diabetes #LiverHealth #HealthSpan